(Q45855332)

English

Development of a factor VIII inhibitor in a newborn haemophiliac

scientific article published in September 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9873883

Development of a factor VIII inhibitor in a newborn haemophiliac (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9873883

0 references

Coagulation factor VIII

0 references

author name string

Haya S

1

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9873883

Lorenzo JI

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9873883

Dasí MA

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9873883

Aznar JA

4

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9873883

publication date

1 September 1998

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9873883

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9873883

4

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9873883

5

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9873883

755-756

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9873883

Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00178.X

21 January 2018

Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIII.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00178.X

21 January 2018

Factor VIII and factor IX inhibitors in haemophiliacs

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00178.X

21 January 2018

Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00178.X

21 January 2018

Identifiers

10.1046/J.1365-2516.1998.00178.X

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9873883

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/9873883

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45855332&oldid=2086699422"